SILDENAFIL-ISPL 50 sildenafil (as citrate) 50 mg capsule blister pack

Ország: Ausztrália

Nyelv: angol

Forrás: Department of Health (Therapeutic Goods Administration)

Vedd Meg Most

Aktív összetevők:

sildenafil citrate, Quantity: 70.24 mg (Equivalent: sildenafil, Qty 50 mg)

Beszerezhető a:

iX Biopharma Pty Ltd

Gyógyszerészeti forma:

Capsule

Összetétel:

Excipient Ingredients: croscarmellose sodium; magnesium stearate; lactose monohydrate; titanium dioxide; tartrazine; sunset yellow FCF; Gelatin; silicon dioxide; sodium lauryl sulfate

Az alkalmazás módja:

Oral

db csomag:

8, 4, 12

Recept típusa:

(S4) Prescription Only Medicine

Terápiás javallatok:

Sildenafil is indicated for the treatment of erectile dysfunction in adult males. ,Sildenafil is not indicated for use by women.

Termék összefoglaló:

Visual Identification: SILDENAFIL-ISPL 50 mg capsules are yellow opaque/yellow opaque size 2 hard gelatin capsules with no markings.; Container Type: Blister Pack; Container Material: PVC/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Engedélyezési státusz:

Registered

Engedély dátuma:

2018-07-31

Termékjellemzők

                                _Sildenafil (as citrate) 25 mg and 50 mg capsules _
_Product Information _
_iX Biopharma Pty Ltd _
Sildenafil capsule PI v2.0 260221
Page 1 of 15
AUSTRALIAN PRODUCT INFORMATION
SILDENAFIL-ISPL (SILDENAFIL) CAPSULES
1
NAME OF THE MEDICINE
Sildenafil (as citrate)
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Excipients with known effect: lactose monohydrate.
For the full list of excipients, see Section 6.1 List of Excipients.
3
PHARMACEUTICAL FORM
Sildenafil-ISPL 25 mg capsules are clear/clear size 2 hard gelatin
capsules with no markings.
Sildenafil-ISPL 50 mg capsules are yellow opaque/yellow opaque size 2
hard gelatin capsules
with no markings.
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
Sildenafil is indicated for the treatment of erectile dysfunction in
adult males. Sildenafil is not
indicated for use by women.
4.2
D
OSE AND METHOD OF ADMINISTRATION
Sildenafil capsules are for oral administration.
USE IN ADULTS
The recommended dose is 50 mg taken as needed approximately one hour
before sexual
activity. Based on the efficacy and toleration, the dose may be
increased to 100 mg or
decreased
to
25
mg.
The
maximum
recommended
dose
is
100
mg.
The
maximum
recommended dosing frequency is once per day.
USE IN CHILDREN
Sildenafil is not indicated for use in children.
DOSAGE ADJUSTMENT IN RENAL IMPAIRMENT
The dosing recommendations for USE IN ADULTS should be followed for
patients with mild to
moderate renal impairment (Cl
cr
= 30-80 mL/min).
Since
sildenafil
clearance
is
reduced
in
patients
with
severe
renal
impairment
(Cl
cr
<30 mL/min) a 25 mg starting dose should be considered. Based on
efficacy and toleration,
the dose may be increased to 50 mg and 100 mg.
DOSAGE ADJUSTMENT IN HEPATIC IMPAIRMENT
Since sildenafil clearance is reduced in patients with hepatic
impairment (e.g., cirrhosis) a
25 mg starting dose should be considered. Based on efficacy and
toleration, the dose may be
increased to 50 mg and 100 mg.
_Sildenafil (as citrate) 25 mg and 50 mg capsules _
_Product Information _
_iX Biopharma Pty Ltd _
Silde
                                
                                Olvassa el a teljes dokumentumot